Abstract
The last 10 years have seen substantial progress in the development and application of nonviral vectors in gene therapy. Several novel nonviral methods have been developed that approach viruses with respect to transfection efficiency. A variety of nonviral delivery systems that can be used for gene therapy in different clinical settings are also available. In this review article, we will detail all of the major nonviral vectors that are currently used in gene therapy while highlighting some recent developments, particularly the progress towards the understanding of the cellular and in vivo barriers in gene transfer. Recent advancement in achieving sustained and regulated gene expression will also be addressed. Finally, this review will briefly cover targeted gene repair using nonviral delivery systems. Their impact in gene therapy will also be discussed.
Keywords: Nonviral Gene Therapy, plasmid DNA, chloramphenicol acetyltransferase gene (CAT), Plasmid DNA-Mediated Gene Transfer, Gene Gun, Anionic Liposomes, Cationic Liposomes, Cholesterol-anchored lipids, Single chain hydrocaron-anchored lipids
Current Gene Therapy
Title: Nonviral Gene Therapy
Volume: 1 Issue: 2
Author(s): Song Li and Zheng Ma
Affiliation:
Keywords: Nonviral Gene Therapy, plasmid DNA, chloramphenicol acetyltransferase gene (CAT), Plasmid DNA-Mediated Gene Transfer, Gene Gun, Anionic Liposomes, Cationic Liposomes, Cholesterol-anchored lipids, Single chain hydrocaron-anchored lipids
Abstract: The last 10 years have seen substantial progress in the development and application of nonviral vectors in gene therapy. Several novel nonviral methods have been developed that approach viruses with respect to transfection efficiency. A variety of nonviral delivery systems that can be used for gene therapy in different clinical settings are also available. In this review article, we will detail all of the major nonviral vectors that are currently used in gene therapy while highlighting some recent developments, particularly the progress towards the understanding of the cellular and in vivo barriers in gene transfer. Recent advancement in achieving sustained and regulated gene expression will also be addressed. Finally, this review will briefly cover targeted gene repair using nonviral delivery systems. Their impact in gene therapy will also be discussed.
Export Options
About this article
Cite this article as:
Li Song and Ma Zheng, Nonviral Gene Therapy, Current Gene Therapy 2001; 1(2) . https://dx.doi.org/10.2174/1566523013348814
DOI https://dx.doi.org/10.2174/1566523013348814 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Epigenetic Modulation of Myocardial Angiogenic Balance: An Emerging Therapeutic Perspective for Adult Failing Heart
Current Angiogenesis (Discontinued) Current Concepts in the Management of Diabetic Polyneuropathy
Current Diabetes Reviews Calreticulin in the Heart: From Embryological Development to Cardiac Pathology.
Current Molecular Medicine Functional and Structural Alterations of Large Arteries: Methodological Issues
Current Pharmaceutical Design Exosomes in Therapy: Engineering, Pharmacokinetics and Future Applications
Current Drug Targets Toll Like Receptors Signaling Pathways as a Target for Therapeutic Interventions
Current Signal Transduction Therapy Detection and Transport Mechanisms of Circulating microRNAs in Neurological, Cardiac and Kidney Diseases
Current Medicinal Chemistry Magnesium Lithospermate B Extracted from Salvia Miltiorrhiza, A Potential Substitute for Cardiac Glycosides
Mini-Reviews in Organic Chemistry Genetics of Hypertrophic and Dilated Cardiomyopathy
Current Pharmaceutical Biotechnology A3 Receptor Ligands: Past, Present and Future Trends
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Pharmacologic Strategies with Afterload Reduction in Low Cardiac Output Syndrome After Pediatric Cardiac Surgery)
Current Vascular Pharmacology Adverse Drug Reactions and Safety Considerations of NSAIDs: Clinical Analysis
Current Drug Safety Leptin Induces Neuroprotection Neurogenesis and Angiogenesis after Stroke
Current Neurovascular Research Progress Towards the Development of Anti-Inflammatory Inhibitors of IKKβ
Current Topics in Medicinal Chemistry Sirtuin Modulators: Mechanisms and Potential Clinical Implications
Current Medicinal Chemistry Endothelial Function: A Surrogate Endpoint in Cardiovascular Studies?
Current Pharmaceutical Design Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Current Pharmaceutical Design Biology and Therapeutic Applications of Peroxisome Proliferator- Activated Receptors
Current Topics in Medicinal Chemistry Iptakalim Hydrochloride and Neuronal Protection
Current Neuropharmacology Application of Mitochondria-Targeted Pharmaceuticals for the Treatment of Heart Disease
Current Pharmaceutical Design